$1.96
-0.04-1.75%
At close: -
$2.05
0.094.59%
After Hours: Dec 18, 9:04 AM EDT
Comments
Loading...
Immuron (NASDAQ:IMRN) Stock Quotes, Forecast and News Summary
Immuron Stock (NASDAQ: IMRN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Immuron (IMRN) stock?
You can purchase shares of Immuron (NASDAQ:IMRN) through any online brokerage.
Who are Immuron (IMRN) competitors?
Other companies in Immuron’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Acurx Pharmaceuticals (NASDAQ:ACXP), Imunon (NASDAQ:IMNN), Cellectar Biosciences (NASDAQ:CLRB) and Sensei Biotherapeutics (NASDAQ:SNSE).
What is the forecast, or price target, for Immuron (IMRN) stock?
Immuron has a consensus price target of $5.00.
What is the current price for Immuron (IMRN)?
The stock price for Immuron (NASDAQ: IMRN) is $2.05 last updated December 18, 2024 at 9:04 AM EST.
Does Immuron (IMRN) pay a dividend?
There are no upcoming dividends for Immuron.
When is Immuron (NASDAQ:IMRN) reporting earnings?
Immuron’s H1 earnings are confirmed for Wednesday, February 26, 2025.
Is Immuron (IMRN) going to split?
There is no upcoming split for Immuron.
What sector and industry does Immuron (IMRN) operate in?
Immuron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.